SARS‐CoV‐2 Evolution: Immune Dynamics, Omicron Specificity, and Predictive Modeling in Vaccinated Populations
Advanced Science · 2024
DOI: 10.1002/advs.202402639 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Xiaohan Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing …. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19 Vaccines, COVID-19, Antibodies, Neutralizing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Beijing Municipal Natural Science Foundation, Capital Health Development Research Project.
Abstract (Originalsprache)
Host immunity is central to the virus's spread dynamics, which is significantly influenced by vaccination and prior infection experiences. In this work, we analyzed the co‐evolution of SARS‐CoV‐2 mutation, angiotensin‐converting enzyme 2 (ACE2) receptor binding, and neutralizing antibody (NAb) responses across various variants in 822 human and mice vaccinated with different non‐Omicron and Omicron vaccines is analyzed. The link between vaccine efficacy and vaccine type, dosing, and post‐vaccination duration is revealed. The classification of immune protection against non‐Omicron and Omicron variants is co‐evolved with genetic mutations and vaccination. Additionally, a model, the Prevalence Score (P‐Score) is introduced, which surpasses previous algorithm‐based models in predicting the potential prevalence of new variants in vaccinated populations. The hybrid vaccination combining the wild‐type (WT) inactivated vaccine with the Omicron BA.4/5 mRNA vaccine may provide broad protection against both non‐Omicron variants and Omicron variants, albeit with EG.5.1 still posing a risk. In conclusion, these findings enhance understanding of population immunity variations and provide valuable insights for future vaccine development and public health strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, 102206, China.
- School of Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
- Department of Virology, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, 100071, China.
- Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.
- Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Beijing, 100020, China.
- Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, 100730, China.
ORCID-Profile: Xiaobo Yu
Förderung
- National Key R&D Program of China
- Beijing Municipal Natural Science Foundation
- Capital Health Development Research Project
- Beijing Municipal International Cooperation and Exchange Project
- State Key Laboratory of Proteomics
- Science and Technology Planning Project of Guangdong Province
- Guangdong-PHOENIX Center Joint Lab on Chinese Medicine
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
Zitieren
APA
Zhang, X., Li, M., Zhang, N., Li, Y., Teng, F., Li, Y., Zhang, X., Xu, X., Li, H., Zhu, Y., Wang, Y., Jia, Y., Qin, C., Wang, B., Guo, S., Wang, Y., & Yu, X. (2024). SARS‐CoV‐2 Evolution: Immune Dynamics, Omicron Specificity, and Predictive Modeling in Vaccinated Populations. Advanced Science. https://doi.org/10.1002/advs.202402639
Vancouver
Zhang X, Li M, Zhang N, Li Y, Teng F, Li Y, et al. SARS‐CoV‐2 Evolution: Immune Dynamics, Omicron Specificity, and Predictive Modeling in Vaccinated Populations. Advanced Science. 2024. doi:10.1002/advs.202402639
BibTeX
@article{Zhang2024,
author = {Zhang, Xiaohan and Li, Mansheng and Zhang, Nana and Li, Yunhui and Teng, Fei and Li, Yongzhe and Zhang, Xiaomei and Xu, Xingming and Li, Haolong and Zhu, Yunping and Wang, Yumin and Jia, Yan and Qin, Chengfeng and Wang, Bingwei and Guo, Shubin and Wang, Yajie and Yu, Xiaobo},
title = {SARS‐CoV‐2 Evolution: Immune Dynamics, Omicron Specificity, and Predictive Modeling in Vaccinated Populations},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202402639}
}
EUVIMED